BC
ELGX

Broadfin Capital’s Endologix Inc ELGX Stock Holding History

Broadfin Capital’s Portfolio ELGX Stock Details ELGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-77,934
Closed -$3.79M – 57
2017
Q2 		$3.79M Sell
77,934
-88,968
-53% -$5.24M 0.46% 42
2017
Q1 		$12.1M Buy
166,902
+16,902
+11% +$1.12M 1.46% 23
2016
Q4 		$8.58M Buy
150,000
+70,000
+88% +$6.41M 0.95% 35
2016
Q3 		$10.2M Sell
80,000
-20,000
-20% -$2.56M 0.92% 32
2016
Q2 		$12.5M Hold
100,000
– – 1.21% 22
2016
Q1 		$8.36M Hold
100,000
– – 0.81% 32
2015
Q4 		$9.9M Buy
+100,000
New +$10.7M 0.61% 45

Other funds holding ELGX

ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Broadfin Capital's ELGX Position: Q3 2017 in Review

Broadfin Capital sold out of Endologix Inc (ELGX) in Q3 2017, closing a stake of 77,934 shares — an estimated $3.79M sold.

Broadfin Capital first reported a position in ELGX in Q4 2015 and held it in 7 quarters. The position peaked at $12.5M in Q2 2016. 106 funds tracked by Wall St. Rank hold ELGX as of Q3 2017.

  • Broadfin Capital reported no remaining Endologix Inc position as of Q3 2017 after selling out during the quarter.
  • Broadfin Capital sold 77,934 Endologix Inc shares in Q3 2017, an estimated $3.79M.
  • Broadfin Capital first reported a position in Endologix Inc in Q4 2015 and held it in 7 quarters.
  • Broadfin Capital's Endologix Inc position peaked at $12.5M in Q2 2016.
  • 106 funds tracked by Wall St. Rank held Endologix Inc as of Q3 2017.

Based on Broadfin Capital's 13F filing for Q3 2017, filed 14 Nov 2017.